Results 51 to 60 of about 13,974 (214)

Moyamoya Disease Developing from Unilateral Moyamoya Disease

Neurologia medico-chirurgica, 1991
The authors report a case of unilateral moyamoya disease which developed into moyamoya disease 3 years later. Unilateral moyamoya disease is generally defined as moyamoya disease, but the exact relationship is unknown. In this case, occlusive changes developed in the stenotic carotid fork, and in a similar portion contralaterally which was intact ...
K, Kurose, H, Kishi, Y, Nishijima
openaire   +3 more sources

Impact of Isovolemic Hemodilution‐Red Cell Exchange on Health‐Related Quality of Life in Patients With Sickle Cell Disease: A Pilot Study

Journal of Clinical Apheresis, Volume 41, Issue 1, February 2026.
ABSTRACT Sickle cell disease (SCD) negatively affects health‐related quality of life (HRQoL). Isovolemic hemodilution (IHD) red‐cell exchange (RCE) is being increasingly used to treat SCD‐related complications, but its impact on HRQoL has not been characterized.
Alistair Murray, Davinder Sidhu, Natalia Rydz, Dawn Goodyear, Kelsey Uminski   +4 more
wiley   +1 more source

Clinical and genetic factors associated with contralateral progression in unilateral moyamoya disease: Longitudinal and Cross-Sectional Study

Heliyon
Objective: This study aimed to explore the long-term outcome of unilateral moyamoya disease and predict the clinical and genetic factors associated with contralateral progression in unilateral moyamoya disease.
Xiao-Peng Wang, Zheng-Xing Zou, Xiang-Yang Bao, Qian-Nan Wang, Bin Ren, Dan Yu, Qian Zhang, Jia-Qi Liu, Fang-Bin Hao, Gan Gao, Qing-Bao Guo, He-Guan Fu, Jing-Jie Li, Min-Jie Wang, Si-Meng Liu, Lian Duan   +15 more
doaj   +1 more source

Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Although antiplatelet agents are frequently prescribed in moyamoya disease in routine clinical practice, there are no large‐scale epidemiologic trials or randomized trial evidence to support their use in patients with moyamoya disease. Methods
Woo‐Keun Seo, Jae‐Young Kim, Eun‐Hyeok Choi, Ye‐Sel Kim, Jong‐Won Chung, Jeffrey L. Saver, Oh Young Bang, Gyeong‐Moon Kim   +7 more
doaj   +1 more source

Limb-shaking syndrome derived from the contralateral hemisphere following unilateral revascularisation for moyamoya disease [PDF]

, 2021
Munehiro Demura, Masahiro Oishi, Naoyuki Uchiyama, Masanao Mohri, K Miyashita, Mitsutoshi Nakada   +5 more
openalex   +1 more source

Bidirectional crusher gradient method to estimate the labeling efficiency of pseudo‐continuous arterial spin labeling MRI in mice

Magnetic Resonance in Medicine, Volume 95, Issue 2, Page 912-926, February 2026.
Abstract Purpose To develop an experimental method for measuring the labeling efficiency of pseudo‐continuous arterial spin labeling (pCASL) MRI in mice. Methods We propose a method using bidirectional crusher gradients to modulate vascular signals in the azygos pericallosal artery (azPA) of the mouse brain, applied with and without pCASL labeling. The
Xiuli Yang, Yuguo Li, Adnan Bibic, Maria Guadalupe Mora Alvarez, Hanzhang Lu, Zhiliang Wei   +5 more
wiley   +1 more source

Diagnosis and Management of Moyamoya Disease

Case Reports in Neurology, 2020
Moyamoya disease is an uncommon vascular disease, which causes obstruction and stenosis of arteries of the circle of Willis, and preferentially affects children and young adults. This disease is seen across the world, but is more common in East Asia.
Shinichiro Uchiyama, Masako Yamazaki, Tatsuya Ishikawa, Koji Yamaguchi, Takakazu Kawamata   +4 more
doaj   +1 more source

Computational Modelling of Cerebral Blood Flow Rate at Different Stages of Moyamoya Disease in Adults and Children

Bioengineering, 2023
Moyamoya disease is a cerebrovascular disorder which causes a decrease in the cerebral blood flow rate. In this study, a lumped parameter model describing the pressures and flow rates in the heart chambers, circulatory system, and cerebral circulation ...
Surhan Bozkurt, Selim Bozkurt
doaj   +1 more source

Endovascular Therapy Versus Best Medical Treatment in Posterior Cerebral Artery Stroke: A Systematic Review and Meta‐Analysis

Brain and Behavior, Volume 16, Issue 1, January 2026.
Graphical abstract representing key findings of our study. ABSTRACT Introduction Posterior cerebral artery (PCA) stroke, while comprising a smaller proportion of ischemic strokes, often results in significant neurological deficits and poses distinctive therapeutic challenges.
Umama Alam, Rabia Ahmed, Shree Rath, Fazia Khattak, Muhammad Asad Asif, Monsurah Bisola Alatise, Lubaba Yunas, Adil Khan, Mohd Sijad Uddin, Labannya Das Puja, Sayed Inamullah, Mahin Fatima, Sumia Fatima, Fazeela Bibi, Abdul Moiz, Raheel Ahmed   +15 more
wiley   +1 more source

Decreased 24‐hour Parasympathetic Activity following Intracerebral Hemorrhage: A Key Factor Correlated with Adverse Perihematomal Edema and Poor Functional Outcomes

CNS Neuroscience &Therapeutics, Volume 32, Issue 1, January 2026.
This study investigated associations between 24‐hour heart rate variability (HRV)‐assessed autonomic activity and perihematomal edema (PHE) development plus functional outcomes in 312 intracerebral hemorrhage (ICH) patients. Parasympathetic hypoactivity (low high‐frequency power) independently correlated with poor 3‐month outcomes (modified Rankin ...
Kaijiang Kang, Zeqiang Ji, Yunyi Hao, Jianwei Wu, Yani Zhang, Haiyan Li, Hui Lin, Yuhao Guo, Chuanying Wang, Yang Du, Guangshuo Li, Yongshi Yao, Yijun Lin, Zheng Liu, Jiexin Liu, Xingquan Zhao   +15 more
wiley   +1 more source